3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Other hematologic neoplasm
15
Myeloid
8
Thoracic
1
Lymphoid
1
Dermatologic
1
Classical hematology
1
Breast
1
Interventions
lutetium Lu 177 dotatate
10
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
pembrolizumab
3
cabozantinib
3
X-Rays
3
Everolimus
3
olaparib
2
fludarabine
2
Phantoms, Imaging
2
Cyclophosphamide
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
repotrectinib
1
peposertib
1
pazopanib
1
lenvatinib
1
fludarabine phosphate
1
entrectinib
1
belinostat
1
aldesleukin
1
Yttrium-90
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Sunitinib
1
Single Photon Emission Computed Tomography Computed Tomography
1
Salts
1
Positron Emission Tomography Computed Tomography
1
Photons
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
decitabine and cedazuridine drug combination
×
NET
×
30 days
×
Clear all
No trials found.